Cabaletta Bio Inc (CABA)
1.2600 x 20 1.3200 x 6
Post-market by (Cboe BZX)
1.2800 -0.0300 (-2.29%) 04/29/25 [NASDAQ]
1.2600 x 20 1.3200 x 6
Post-market 1.2600 -0.0200 (-1.56%) 19:43 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select FieldsSymbol | CABA | ADAG | VTGN | ||
Company | Cabaletta Bio Inc | Adagene Inc ADR | Vistagen Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.3200 | 1.4300 | 2.28 | ||
High | 1.3250 | 1.4400 | 2.32 | ||
Low | 1.2400 | 1.4100 | 2.25 | ||
Last | 1.2800 | 1.4100 | 2.29 | ||
Change | -0.0300 | -0.0200 | unch | ||
% Change | -2.29% | -1.40% | unch | ||
Volume | 388,200 | 6,100 | 41,400 | ||
20-Day Average Volume | 875,190 | 19,015 | 120,245 | ||
Previous Close | 1.3100 | 1.4300 | 2.29 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.1862 | 1.5218 | 2.19 | ||
20-Day Raw Stochastic | 71.36% | 14.29% | 61.90% | ||
20-Day Relative Strength | 43.21% | 40.00% | 46.73% | ||
Weighted Alpha | -87.58 | -47.53 | -52.23 | ||
Today's Opinion | 88% Sell | 100% Sell | 88% Sell | ||
Previous Opinion | 88% Sell | 100% Sell | 88% Sell | ||
Last Month's Opinion | 100% Sell | 100% Sell | 80% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | unch since 04/22/25 | -2.76% since 04/22/25 | +11.71% since 04/22/25 | ||
Low | 1.2300 on 04/25/25 | 1.3600 on 04/24/25 | 2.08 on 04/23/25 | ||
High | 1.3900 on 04/23/25 | 1.5348 on 04/23/25 | 2.34 on 04/25/25 | ||
1-Month | |||||
%Chg | -17.42% since 03/28/25 | -9.32% since 03/28/25 | -11.58% since 03/28/25 | ||
Low | 0.9900 on 04/07/25 | 1.3250 on 04/01/25 | 1.90 on 04/09/25 | ||
High | 1.5100 on 03/31/25 | 1.9200 on 04/16/25 | 2.55 on 03/31/25 | ||
3-Month | |||||
%Chg | -45.99% since 01/29/25 | -23.78% since 01/29/25 | -19.93% since 01/29/25 | ||
Low | 0.9900 on 04/07/25 | 1.3250 on 04/01/25 | 1.90 on 04/09/25 | ||
High | 2.9000 on 02/18/25 | 2.2700 on 02/27/25 | 3.10 on 02/14/25 | ||
6-Month | |||||
%Chg | -69.52% since 10/29/24 | -54.52% since 10/29/24 | -24.92% since 10/29/24 | ||
Low | 0.9900 on 04/07/25 | 1.3250 on 04/01/25 | 1.90 on 04/09/25 | ||
High | 5.4600 on 12/02/24 | 3.1500 on 11/06/24 | 3.39 on 01/03/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 66,473 | 67,367 | 66,094 | ||
Shares Outstanding, K | 50,743 | 47,110 | 28,862 | ||
Annual Sales | 0 | 100,000 | 1,060,000 | ||
Annual Net Income | -115,860,000 | -33,420,000 | -29,360,000 | ||
Last Quarter Sales | 0 | 391,413 | 230,000 | ||
Last Quarter Net Income | -32,590,000 | -12,767,865 | -14,090,000 | ||
60-Month Beta | 2.44 | 0.61 | 0.56 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.65 on 03/31/25 | N/A | -0.46 on 02/13/25 | ||
Latest Earnings Date | 05/21/25 | 04/04/25 | 06/10/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |